Developing biomarkers for cerebral amyloid angiopathy trials: Do potential disease phenotypes hold promise? - Authors' reply

Steven M. Greenberg; Rustam Al Shahi Salman; Geert Jan Biessels; Mark Van Buchem; Charlotte Cordonnier; Jin Moo Lee; Joan Montaner; Julie A. Schneider; Eric E. Smith; Meike Vernooij; David J. Werring

doi:10.1016/S1474-4422(14)70097-3

Developing biomarkers for cerebral amyloid angiopathy trials: Do potential disease phenotypes hold promise? - Authors' reply

Steven M. Greenberg
, Rustam Al Shahi Salman
, Geert Jan Biessels
, Mark Van Buchem
, Charlotte Cordonnier
, Jin Moo Lee
, Joan Montaner
, Julie A. Schneider
, Eric E. Smith
, Meike Vernooij
, David J. Werring

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	540
Number of pages	1
Journal	The Lancet Neurology
Volume	13
Issue number	6
DOIs	https://doi.org/10.1016/S1474-4422(14)70097-3
State	Published - Jun 2014

Access to Document

10.1016/S1474-4422(14)70097-3

Cite this

Greenberg, S. M., Salman, R. A. S., Biessels, G. J., Van Buchem, M., Cordonnier, C., Lee, J. M., Montaner, J., Schneider, J. A., Smith, E. E., Vernooij, M., & Werring, D. J. (2014). Developing biomarkers for cerebral amyloid angiopathy trials: Do potential disease phenotypes hold promise? - Authors' reply. The Lancet Neurology, 13(6), 540. https://doi.org/10.1016/S1474-4422(14)70097-3

@article{25091e9e6b8644f9aeeb1869706be654,

title = "Developing biomarkers for cerebral amyloid angiopathy trials: Do potential disease phenotypes hold promise? - Authors' reply",

author = "Greenberg, \{Steven M.\} and Salman, \{Rustam Al Shahi\} and Biessels, \{Geert Jan\} and \{Van Buchem\}, Mark and Charlotte Cordonnier and Lee, \{Jin Moo\} and Joan Montaner and Schneider, \{Julie A.\} and Smith, \{Eric E.\} and Meike Vernooij and Werring, \{David J.\}",

year = "2014",

month = jun,

doi = "10.1016/S1474-4422(14)70097-3",

language = "English",

volume = "13",

pages = "540",

journal = "The Lancet Neurology",

issn = "1474-4422",

number = "6",

}

Greenberg, SM, Salman, RAS, Biessels, GJ, Van Buchem, M, Cordonnier, C, Lee, JM, Montaner, J, Schneider, JA, Smith, EE, Vernooij, M & Werring, DJ 2014, 'Developing biomarkers for cerebral amyloid angiopathy trials: Do potential disease phenotypes hold promise? - Authors' reply', The Lancet Neurology, vol. 13, no. 6, pp. 540. https://doi.org/10.1016/S1474-4422(14)70097-3

TY - JOUR

T1 - Developing biomarkers for cerebral amyloid angiopathy trials

T2 - Do potential disease phenotypes hold promise? - Authors' reply

AU - Greenberg, Steven M.

AU - Salman, Rustam Al Shahi

AU - Biessels, Geert Jan

AU - Van Buchem, Mark

AU - Cordonnier, Charlotte

AU - Lee, Jin Moo

AU - Montaner, Joan

AU - Schneider, Julie A.

AU - Smith, Eric E.

AU - Vernooij, Meike

AU - Werring, David J.

PY - 2014/6

Y1 - 2014/6

UR - https://www.scopus.com/pages/publications/84901005988

U2 - 10.1016/S1474-4422(14)70097-3

DO - 10.1016/S1474-4422(14)70097-3

M3 - Letter

C2 - 24849857

AN - SCOPUS:84901005988

SN - 1474-4422

VL - 13

SP - 540

JO - The Lancet Neurology

JF - The Lancet Neurology

IS - 6

ER -

Developing biomarkers for cerebral amyloid angiopathy trials: Do potential disease phenotypes hold promise? - Authors' reply

Access to Document

Other files and links

Cite this